SynaGeva BioPharma

Alexion Pharma to pay $8.4 billion for rare disease treatment developer Synageva BioPharma
Yahoo/AP
Wed, 05/6/15 - 09:00 am
Alexion
M&A
SynaGeva BioPharma
Shire’s Next Targets Could Be on This List: Real M&A
Bloomberg
Wed, 01/14/15 - 10:00 am
Shire
M&A
PTC Therapeutics
SynaGeva BioPharma
Retrophin
Ultragenyx
Vertex Pharmaceuticals
Biomarin
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 05/18/13 - 11:54 am
Infinity Pharmaceuticals
Gilead Sciences
SynaGeva BioPharma
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
3 Biotech Stocks to Avoid in 2013
Motley Fool
Wed, 01/2/13 - 12:00 pm
SynaGeva BioPharma
Clovis Oncology
Forest Labs